![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Temad Morphine Sulfate](https://www.pharmacompass.com/image/flap/temad-morphine-sulfate-desktop-headergif-78150.gif)
![Temad Morphine Sulfate](https://www.pharmacompass.com/image/flap/temad-morphine-sulfate-mobile-headergif-25559.gif)
Active Filter(s):
Details:
U.S. Food and Drug Administration approved the Company’s Abbreviated New Drug Application for Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet® Prefilled Syringe System.
Lead Product(s): Morphine Sulfate
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 03, 2021